UNION CITY, Calif.,
July 18, 2017 /PRNewswire/ -- Abaxis,
Inc. (Nasdaq: ABAX), a global diagnostics company manufacturing
point-of-care blood analysis instruments and consumables for the
medical and veterinary markets worldwide, has scheduled a
conference call to discuss its financial results for the first
quarter fiscal year 2018, ended June 30,
2017. The call will be at 4:15 p.m.
ET on Thursday, July 27,
2017. The Company will report financial results for the first
quarter fiscal year 2018 after market close on Thursday, July 27, 2017.
Participants can dial (844) 855-9498 or (412) 317-5496 to access
the conference call, or can listen via a live Internet web cast,
which is available in the Investor Relations section of the
Company's website at www.abaxis.com. A replay of the call is
available by visiting www.abaxis.com for the next 30 days or by
calling (877) 344-7529 or (412) 317-0088, confirmation code
10110686, through August 3, 2017.
About Abaxis
Abaxis, Inc. is a worldwide developer, manufacturer and marketer of
portable blood analysis systems that are used in a broad range of
medical specialties in human or veterinary patient care to provide
clinicians with rapid blood constituent measurements. Our
mission is to improve the efficiency of care delivery to and the
quality of life of patients in the medical and veterinary
markets. We provide leading edge technology and tools that
support best medical practices, enabling physicians and
veterinarians to respond to the health needs of their clients at
the point of care while operating economical and profitable
practices. For more information, visit
http://www.abaxis.com
Contact:
|
Clint
Severson
|
Lytham Partners,
LLC
|
|
Chief Executive
Officer
|
Joe Dorame, Joe Diaz
& Robert Blum
|
|
Abaxis,
Inc.
|
602-889-9700
|
|
510-675-6500
|
|
View original
content:http://www.prnewswire.com/news-releases/abaxis-to-report-first-quarter-fiscal-year-2018-financial-results-on-thursday-july-27-2017-300489690.html
SOURCE Abaxis, Inc.